Matthew Wiley

Matthew Wiley

Corporate Officer/Principal at DEFINIUM THERAPEUTICS, INC.

Net worth: 14 M $ as of 31/08/2026

54 year
Health Technology
Consumer Services

Profile

Matthew T.
Wiley
is Chief Commercial Officer at Definium Therapeutics, Inc. since 2025.
Former roles include Chief Commercial Officer & Senior Vice President at BioXcel Therapeutics, Inc. from 2022 to 2024; Chief Commercial Officer at VYNE Pharmaceuticals Ltd. from 2018 to 2020; Vice President-Marketing at Jazz Pharmaceuticals, Inc. from 2012 to 2018; Vice President-Marketing at Jazz Pharmaceuticals Commercial Corp.
from 2007 to 2012; and Chief Commercial Officer at Menlo Therapeutics, Inc. Education includes undergraduate studies at Syracuse University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
25/09/2026 359,036 ( 0.27% ) 14 M $ 31/08/2026

Matthew Wiley active positions

CompaniesPositionStart
DEFINIUM THERAPEUTICS, INC. Corporate Officer/Principal 17/03/2025

Former positions of Matthew Wiley

CompaniesPositionEnd
BIOXCEL THERAPEUTICS, INC. Corporate Officer/Principal 02/10/2024
Corporate Officer/Principal 09/03/2020
Sales & Marketing 01/01/2018
Sales & Marketing 01/01/2012
Sales & Marketing -
See the detail of Matthew Wiley's experience

Training of Matthew Wiley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology